URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

James Mason

Concepts (348)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Telomere
12
2002
27
4.520
Why?
Drosophila melanogaster
10
2002
64
3.320
Why?
Hypertension
7
2003
285
2.240
Why?
Drosophila Proteins
5
2002
81
2.010
Why?
Drosophila
3
2004
78
1.510
Why?
DNA Breaks, Double-Stranded
2
2009
23
1.400
Why?
Retroelements
6
2003
30
1.170
Why?
DNA-Binding Proteins
3
2008
661
1.110
Why?
Diabetes Mellitus
4
2003
162
1.070
Why?
Chromosomal Proteins, Non-Histone
4
2002
17
1.070
Why?
Pancreatitis
2
2007
28
0.860
Why?
Life Style
5
2004
80
0.850
Why?
Wound Healing
5
2003
196
0.770
Why?
Gene Silencing
4
2003
42
0.770
Why?
Practice Guidelines as Topic
4
2004
288
0.750
Why?
Heterochromatin
3
2002
17
0.740
Why?
Evidence-Based Medicine
5
2002
197
0.720
Why?
DNA Transposable Elements
3
2002
41
0.710
Why?
Chromosomes
3
2005
34
0.690
Why?
Cost-Benefit Analysis
4
2004
200
0.620
Why?
Animals
21
2001
15647
0.610
Why?
Relaxation Therapy
1
2008
15
0.610
Why?
Hyperlipidemias
2
2003
43
0.590
Why?
Antihypertensive Agents
2
2004
77
0.570
Why?
Terminal Repeat Sequences
2
2003
6
0.560
Why?
Diabetes Mellitus, Experimental
2
2003
78
0.560
Why?
Severity of Illness Index
1
2010
878
0.550
Why?
Diabetes Complications
3
2003
60
0.530
Why?
Economics, Pharmaceutical
1
2006
7
0.530
Why?
Meta-Analysis as Topic
1
2006
36
0.520
Why?
Sodium Chloride Symporter Inhibitors
1
2005
10
0.520
Why?
Euchromatin
1
2005
1
0.510
Why?
Adrenergic beta-Antagonists
1
2005
152
0.490
Why?
Flavoproteins
1
2004
6
0.490
Why?
Diabetic Angiopathies
1
2005
31
0.480
Why?
Amino Acid Oxidoreductases
1
2004
39
0.480
Why?
Lysosomes
1
2004
51
0.470
Why?
Transduction, Genetic
2
2003
111
0.460
Why?
Transcription, Genetic
2
2007
795
0.450
Why?
Femur Head Necrosis
1
2003
5
0.450
Why?
Cementation
1
2003
15
0.450
Why?
Humans
32
2002
35000
0.440
Why?
Bone Cements
1
2003
14
0.440
Why?
Hip Prosthesis
1
2003
32
0.440
Why?
Cold Temperature
1
2003
97
0.440
Why?
Arthroplasty, Replacement, Hip
1
2003
34
0.430
Why?
Health Care Costs
1
2004
99
0.430
Why?
Leukocytes
1
2004
191
0.430
Why?
Hot Temperature
1
2003
161
0.420
Why?
Mutation
4
2002
1183
0.420
Why?
Transgenes
4
2003
69
0.410
Why?
Models, Biological
2
2003
982
0.410
Why?
Transforming Growth Factor beta
2
2001
362
0.400
Why?
Gene Products, gag
1
2002
17
0.400
Why?
Immediate-Early Proteins
1
2001
32
0.380
Why?
Collagen Type I
1
2001
46
0.380
Why?
Growth Substances
1
2001
96
0.380
Why?
Intercellular Signaling Peptides and Proteins
1
2001
108
0.360
Why?
DNA Repair
3
2009
168
0.360
Why?
Cell Cycle
3
2009
247
0.360
Why?
Extracellular Matrix
1
2001
155
0.340
Why?
RNA, Messenger
2
2001
1791
0.320
Why?
Chromosome Mapping
3
2002
223
0.310
Why?
Base Sequence
4
2003
1681
0.310
Why?
Antioxidants
2
2007
200
0.300
Why?
Models, Genetic
3
2003
157
0.300
Why?
England
5
2002
44
0.290
Why?
Randomized Controlled Trials as Topic
4
2005
400
0.290
Why?
Meiosis
2
2004
27
0.280
Why?
Animals, Genetically Modified
2
2003
54
0.270
Why?
Molecular Sequence Data
3
2003
1993
0.260
Why?
Telephone
2
2005
22
0.250
Why?
Two-Hybrid System Techniques
2
2011
65
0.240
Why?
Immunoprecipitation
2
2011
77
0.240
Why?
Female
14
2002
19061
0.240
Why?
Blood Pressure
3
2003
446
0.240
Why?
Proto-Oncogene Proteins c-sis
2
2003
21
0.240
Why?
Specialties, Nursing
2
2003
3
0.240
Why?
Male
17
2002
18870
0.230
Why?
Judgment
2
2005
14
0.230
Why?
Blotting, Southern
2
2002
103
0.230
Why?
Ambulatory Care
2
2005
140
0.220
Why?
APACHE
2
2007
32
0.220
Why?
Trans-Activators
2
2003
343
0.220
Why?
Research Design
2
2012
326
0.210
Why?
Quality of Life
4
2006
486
0.210
Why?
Pancreatitis, Alcoholic
1
2012
1
0.210
Why?
Pancreatitis, Chronic
1
2012
2
0.210
Why?
Pyoderma Gangrenosum
1
2012
1
0.210
Why?
Prednisolone
1
2012
24
0.200
Why?
Diabetes Mellitus, Type 2
2
2005
208
0.200
Why?
Middle Aged
10
2003
9461
0.200
Why?
Dermatologic Agents
1
2012
24
0.200
Why?
Cellulitis
1
2011
11
0.200
Why?
Leg Dermatoses
1
2011
6
0.200
Why?
Cyclosporine
1
2012
61
0.200
Why?
Aged
9
2003
6986
0.200
Why?
Penicillin V
1
2011
26
0.200
Why?
Transfection
2
2004
833
0.190
Why?
Opioid-Related Disorders
1
2011
22
0.190
Why?
Governing Board
1
2011
1
0.190
Why?
Mice
6
2001
5900
0.190
Why?
Acute Disease
2
2007
570
0.190
Why?
State Medicine
1
2011
17
0.190
Why?
Preventive Medicine
1
2011
34
0.190
Why?
Venous Thrombosis
1
2011
75
0.180
Why?
Aged, 80 and over
4
2005
2423
0.180
Why?
Protein Structure, Tertiary
2
2008
347
0.180
Why?
Area Under Curve
1
2010
61
0.180
Why?
Physicians
1
2012
143
0.180
Why?
Heart Failure
2
2002
337
0.170
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2010
12
0.170
Why?
Adult
8
2005
10906
0.170
Why?
Gene Expression Regulation
2
2003
848
0.170
Why?
Genes, Insect
1
2009
7
0.170
Why?
Delivery of Health Care
1
2011
136
0.160
Why?
Adult Stem Cells
1
2009
22
0.160
Why?
Bone Regeneration
1
2009
33
0.160
Why?
Pain
1
2012
363
0.160
Why?
Glioma
1
2010
92
0.160
Why?
Lentivirus
2
2005
26
0.160
Why?
Health Policy
2
2005
76
0.160
Why?
Adrenal Cortex Hormones
1
2009
98
0.160
Why?
Bone Density Conservation Agents
1
2009
45
0.160
Why?
Psoriasis
1
2009
46
0.160
Why?
Skull
1
2009
117
0.150
Why?
Species Specificity
1
2009
335
0.150
Why?
Vitamin D
1
2009
64
0.150
Why?
Oocytes
1
2009
134
0.150
Why?
Drug Therapy, Combination
2
2005
375
0.150
Why?
Mutagenesis, Insertional
1
2008
52
0.150
Why?
Repetitive Sequences, Nucleic Acid
1
2008
81
0.150
Why?
Dermis
2
2003
7
0.150
Why?
Anti-Bacterial Agents
1
2011
432
0.150
Why?
Evolution, Molecular
1
2008
64
0.150
Why?
Sequence Homology
1
2007
15
0.140
Why?
Chromatin
1
2008
101
0.140
Why?
Treatment Outcome
6
2003
2487
0.140
Why?
Pyruvate Kinase
1
2007
26
0.140
Why?
Histones
1
2009
170
0.140
Why?
Group Processes
1
2006
15
0.140
Why?
Primary Health Care
1
2011
449
0.140
Why?
Fertility
1
2006
48
0.140
Why?
Arsenicals
1
2006
7
0.140
Why?
Phenotype
1
2009
727
0.140
Why?
Longevity
1
2006
27
0.140
Why?
Diet, Sodium-Restricted
1
2006
13
0.130
Why?
Review Literature as Topic
1
2006
8
0.130
Why?
Polymerase Chain Reaction
2
2003
586
0.130
Why?
Pancreatic Neoplasms
1
2007
85
0.130
Why?
Social Support
2
2005
214
0.130
Why?
Oxides
1
2006
21
0.130
Why?
Internationality
1
2006
22
0.130
Why?
Hydrogen-Ion Concentration
2
2004
561
0.130
Why?
Risk Factors
3
2005
2172
0.130
Why?
Femur
2
2003
78
0.130
Why?
Oligonucleotide Array Sequence Analysis
1
2008
278
0.130
Why?
Gene Components
1
2005
2
0.130
Why?
Repressor Proteins
1
2008
171
0.130
Why?
Genomic Library
1
2005
15
0.130
Why?
Insurance, Health, Reimbursement
1
2006
24
0.130
Why?
Genes, sis
1
2005
1
0.130
Why?
Models, Economic
1
2006
27
0.130
Why?
Apoptosis
1
2011
782
0.130
Why?
Physician's Practice Patterns
2
2002
223
0.130
Why?
Nuclear Proteins
1
2009
333
0.120
Why?
Microscopy, Electron
1
2005
374
0.120
Why?
Pigmentation
1
2004
4
0.120
Why?
4-Aminobenzoic Acid
1
2004
1
0.120
Why?
Amino Acids, Aromatic
1
2004
2
0.120
Why?
Benzoic Acid
1
2004
3
0.120
Why?
L-Amino Acid Oxidase
1
2004
3
0.120
Why?
Adolescent
2
2010
4513
0.120
Why?
NIH 3T3 Cells
1
2004
25
0.120
Why?
Computational Biology
1
2005
66
0.120
Why?
Sequence Analysis, DNA
1
2005
161
0.120
Why?
In Situ Hybridization
1
2005
293
0.120
Why?
Mice, Inbred C57BL
3
2003
1613
0.120
Why?
Fractures, Bone
1
2005
85
0.120
Why?
Cell Line
1
2009
1554
0.120
Why?
Cost Allocation
1
2004
2
0.120
Why?
HMGB1 Protein
1
2004
2
0.120
Why?
Myelodysplastic Syndromes
1
2006
129
0.120
Why?
Health Care Rationing
1
2004
8
0.120
Why?
Subcellular Fractions
1
2004
96
0.120
Why?
Genetic Markers
1
2004
127
0.120
Why?
Eye
1
2004
53
0.120
Why?
Gastroenterology
1
2004
10
0.120
Why?
Osteoporosis
1
2005
86
0.120
Why?
Binding, Competitive
1
2004
201
0.120
Why?
DNA Primers
1
2005
401
0.120
Why?
Promoter Regions, Genetic
1
2007
534
0.110
Why?
Quality-Adjusted Life Years
1
2004
50
0.110
Why?
Substrate Specificity
1
2004
224
0.110
Why?
Patient-Centered Care
1
2005
71
0.110
Why?
Finite Element Analysis
1
2003
10
0.110
Why?
Health Services Research
1
2004
104
0.110
Why?
Immunohistochemistry
2
2003
1024
0.110
Why?
Double-Blind Method
3
2007
985
0.110
Why?
Oxidation-Reduction
1
2004
295
0.110
Why?
Retroviridae
1
2003
72
0.110
Why?
Recombination, Genetic
1
2004
173
0.110
Why?
Eye Color
1
2003
1
0.110
Why?
Equipment Failure Analysis
1
2003
68
0.110
Why?
Prosthesis Failure
1
2003
63
0.110
Why?
Blood Glucose
1
2005
451
0.110
Why?
Periosteum
1
2003
21
0.110
Why?
Pharmacists
1
2002
6
0.110
Why?
Models, Chemical
1
2003
101
0.100
Why?
Temperature
1
2003
239
0.100
Why?
Patient Satisfaction
1
2005
216
0.100
Why?
Drug Utilization
1
2002
44
0.100
Why?
Enzyme Inhibitors
1
2004
396
0.100
Why?
Anaphase
1
2002
3
0.100
Why?
Genes, Reporter
1
2003
206
0.100
Why?
Metaphase
1
2002
9
0.100
Why?
Macrophages
1
2004
329
0.100
Why?
Insect Proteins
1
2002
10
0.100
Why?
Guideline Adherence
1
2002
72
0.100
Why?
Algorithms
1
2006
518
0.100
Why?
Education, Medical, Continuing
1
2002
65
0.100
Why?
Left-Right Determination Factors
1
2001
1
0.100
Why?
Connective Tissue Growth Factor
1
2001
2
0.100
Why?
Cartilage, Articular
1
2003
185
0.100
Why?
Genes, Dominant
1
2002
78
0.100
Why?
DNA Probes
1
2002
86
0.100
Why?
Recombinant Proteins
1
2004
706
0.100
Why?
Fibrosarcoma
1
2001
32
0.100
Why?
Matrix Metalloproteinases
1
2001
33
0.100
Why?
Kinetics
1
2004
1377
0.100
Why?
Mitosis
1
2002
99
0.100
Why?
Stem Cell Transplantation
1
2003
108
0.100
Why?
Computer Simulation
1
2003
295
0.090
Why?
Family Practice
1
2002
168
0.090
Why?
Mice, Nude
1
2001
178
0.090
Why?
Transcriptional Activation
1
2003
280
0.090
Why?
Antineoplastic Agents
1
2006
598
0.090
Why?
Polymorphism, Genetic
1
2002
191
0.090
Why?
Fibroblasts
1
2003
514
0.090
Why?
Prospective Studies
3
2006
1606
0.090
Why?
Recurrence
2
2011
656
0.090
Why?
Risk Assessment
3
2005
808
0.080
Why?
Program Evaluation
3
2003
170
0.080
Why?
Great Britain
2
2006
95
0.080
Why?
Protein Binding
2
2008
812
0.070
Why?
Young Adult
2
2011
1013
0.070
Why?
Infusions, Intravenous
2
2006
139
0.070
Why?
Drug Administration Schedule
2
2006
362
0.060
Why?
Time Factors
2
2012
3047
0.060
Why?
Survival Analysis
2
2006
575
0.060
Why?
Exercise
2
2005
155
0.060
Why?
Questionnaires
2
2005
942
0.060
Why?
Prognosis
2
2006
1030
0.050
Why?
Quality Assurance, Health Care
2
2004
114
0.050
Why?
Genetic Vectors
2
2005
328
0.050
Why?
Retrospective Studies
2
2007
2167
0.050
Why?
Ireland
1
2012
8
0.050
Why?
Drug Costs
1
2012
22
0.050
Why?
Uncertainty
1
2012
16
0.050
Why?
Leg Ulcer
1
2011
6
0.050
Why?
Medication Adherence
1
2011
18
0.050
Why?
Costs and Cost Analysis
1
2011
84
0.050
Why?
Administration, Oral
1
2012
302
0.050
Why?
Antibiotic Prophylaxis
1
2011
34
0.050
Why?
Organizational Case Studies
1
2011
10
0.050
Why?
Decision Making, Organizational
1
2011
6
0.050
Why?
Qualitative Research
1
2011
54
0.050
Why?
Focus Groups
1
2011
63
0.050
Why?
Heparin
1
2011
116
0.050
Why?
Pain Measurement
1
2012
241
0.040
Why?
Patient Selection
1
2012
197
0.040
Why?
Anticoagulants
1
2011
128
0.040
Why?
Lucanthone
1
2010
1
0.040
Why?
Cells, Cultured
2
2003
2367
0.040
Why?
Prevalence
1
2011
530
0.040
Why?
Motivation
1
2011
148
0.040
Why?
Biomedical Engineering
1
2009
12
0.040
Why?
Radiation Tolerance
1
2010
78
0.040
Why?
Incidence
1
2011
644
0.040
Why?
Indoles
1
2010
93
0.040
Why?
Administration, Topical
1
2009
88
0.040
Why?
Hospitalization
1
2011
354
0.040
Why?
Micrococcal Nuclease
1
2008
13
0.040
Why?
RNA, Small Interfering
1
2010
180
0.040
Why?
DNA Damage
1
2010
168
0.040
Why?
Cell Line, Tumor
1
2010
543
0.040
Why?
Nucleosomes
1
2008
80
0.040
Why?
Selenium
1
2007
37
0.040
Why?
Chronic Disease
1
2009
496
0.030
Why?
Brain Neoplasms
1
2010
254
0.030
Why?
Ascorbic Acid
1
2007
45
0.030
Why?
Acetylcysteine
1
2007
76
0.030
Why?
Gene Expression
1
2010
723
0.030
Why?
Ovary
1
2006
89
0.030
Why?
Fish Oils
1
2006
9
0.030
Why?
Hematologic Diseases
1
2006
40
0.030
Why?
Administrative Personnel
1
2006
20
0.030
Why?
Calcium, Dietary
1
2006
22
0.030
Why?
Rats, Sprague-Dawley
1
2009
956
0.030
Why?
Disease-Free Survival
1
2006
191
0.030
Why?
Data Interpretation, Statistical
1
2006
154
0.030
Why?
Azo Compounds
1
2005
18
0.030
Why?
Antigens, CD31
1
2005
18
0.030
Why?
Sunlight
1
2005
14
0.030
Why?
Magnesium
1
2006
131
0.030
Why?
Consensus
1
2005
15
0.030
Why?
Coloring Agents
1
2005
52
0.030
Why?
Comprehension
1
2005
26
0.030
Why?
Tumor Markers, Biological
1
2007
221
0.030
Why?
Mice, Inbred Strains
1
2005
238
0.030
Why?
Staining and Labeling
1
2005
161
0.030
Why?
Hemoglobin A, Glycosylated
1
2005
49
0.030
Why?
Immunoenzyme Techniques
1
2005
220
0.030
Why?
Potassium
1
2006
303
0.030
Why?
Diet
1
2006
196
0.030
Why?
Green Fluorescent Proteins
1
2005
205
0.030
Why?
Tumor Necrosis Factors
1
2004
15
0.030
Why?
Cricetulus
1
2004
93
0.030
Why?
Software
1
2005
126
0.030
Why?
Mice, Inbred C3H
1
2004
225
0.030
Why?
DNA, Bacterial
1
2004
167
0.030
Why?
CHO Cells
1
2004
180
0.030
Why?
Patient Compliance
1
2005
170
0.030
Why?
Pilot Projects
1
2005
426
0.030
Why?
Oxidative Stress
1
2007
330
0.030
Why?
Ambulatory Care Facilities
1
2003
28
0.030
Why?
Bone Morphogenetic Protein 7
1
2003
6
0.030
Why?
Cricetinae
1
2004
361
0.030
Why?
Cholesterol
1
2003
130
0.030
Why?
Lipopolysaccharides
1
2004
208
0.030
Why?
Hedgehog Proteins
1
2003
42
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
513
0.030
Why?
Analysis of Variance
1
2005
705
0.030
Why?
Intervention Studies
1
2002
27
0.030
Why?
Knee Joint
1
2003
50
0.030
Why?
Organizational Innovation
1
2002
27
0.030
Why?
Community-Institutional Relations
1
2002
26
0.030
Why?
Bone Morphogenetic Proteins
1
2003
155
0.020
Why?
Tissue Engineering
1
2003
71
0.020
Why?
Osteoarthritis
1
2002
131
0.020
Why?
Rats
1
2009
4185
0.020
Why?
Rabbits
1
2003
686
0.020
Why?
Disease Models, Animal
1
2005
908
0.020
Why?
Escherichia coli
1
2004
519
0.020
Why?
Cytokines
1
2004
555
0.020
Why?
Follow-Up Studies
1
2005
1757
0.020
Why?
Depressive Disorder
1
2002
307
0.020
Why?
Cardiovascular Diseases
1
2002
250
0.020
Why?

Visualizations


Mason's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department